INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 45h ago
HOUSE PTR5h ago
SEC 13F5h ago
ROBINHOOD CHAIN5h ago
SEC FORM 4/Open-market purchaseVerified data

Tpg Gp A, Llc bought ODTX

Former 10% Owner · Odyssey Therapeutics, Inc. · Common Stock

Side
BUY
Value
$25.00M
Shares
1.39M
Price
$18
Executed
May 11, 2026
Disclosed
May 13, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
May 11 executedMay 13, 2026 disclosed

ODTX · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
53/ 100 · NOTABLE
Methodology →
  • Transaction type+20 / 20

    Open-market purchase

  • Relative size+25 / 25

    $25.0M reported value · 60.4% of prior position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · ODTX

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    12
    TA
    Tpg Gp A, LlcFormer 10% Owner
    ODTXOdyssey Therapeutics, Inc.
    Other acquisition or disposition
    		J—
    423.1K sh
    		May 11, 2026May 13, 2026
    traded May 11, 2026
    		+2dSEC FORM 4

    Evidence

    21
    TA
    Tpg Gp A, LlcFormer 10% Owner
    ODTXOdyssey Therapeutics, Inc.
    Derivative conversion
    		C—
    1.88M sh
    		May 11, 2026May 13, 2026
    traded May 11, 2026
    		+2dSEC FORM 4

    Evidence

    12
    TA
    Tpg Gp A, LlcFormer 10% Owner
    ODTXOdyssey Therapeutics, Inc.
    Other acquisition or disposition
    		J—
    423.1K sh
    		May 11, 2026May 13, 2026
    traded May 11, 2026
    		+2dSEC FORM 4

    Evidence

    9
    TA
    Tpg Gp A, LlcFormer 10% Owner
    ODTXOdyssey Therapeutics, Inc.
    Derivative conversion
    		C—
    18.27M sh
    		May 11, 2026May 13, 2026
    traded May 11, 2026
    		+2dSEC FORM 4

    Evidence

    12
    TA
    Tpg Gp A, LlcFormer 10% Owner
    ODTXOdyssey Therapeutics, Inc.
    Other acquisition or disposition
    		J$42K
    2,351 sh
    		May 11, 2026May 13, 2026
    traded May 11, 2026
    		+2dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001999371-26-010652
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    May 11, 2026
    Published
    May 13, 2026
    Ingested by INSIDER
    Nov 5, 03:59 UTC
    Last re-read
    Nov 5, 03:59 UTC

    Extracted facts

    Filer
    Tpg Gp A, Llc
    Role
    Former 10% Owner
    Transaction
    Open-market purchaseAs filed: “P”
    Asset
    Odyssey Therapeutics, Inc.
    Ticker
    ODTX
    Shares
    1.39M
    Price per share
    $18
    Value
    $25,000,002
    Execution date (reported)
    May 11, 2026
    Owned after transaction
    3.69M shares
    Days from execution to publication
    2

    Calculation

    Value = shares × reported price per share

    • Shares: 1.39M
    • Price: $18

    = $25,000,002

    What this establishes

    Tpg Gp A, Llc filed this Form 4 reporting a open-market purchase of ODTX on May 11, 2026. It became public on May 13, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Former 10% Owner
    Tpg Gp A, Llccik:0001903793
    Issuer
    Odyssey Therapeutics, Inc.cik:0001882782

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.